Press Releases

January 27, 2020
Sydnexis Joins the Board of GMAC
GMAC’s mission is to promote public awareness of childhood myopia as a treatable disease
Read More
May 2, 2019
Sydnexis Announces First Patients in Phase 3 Clinical Trial
Announcing the Enrollment of First Patients in Phase 3 Myopia STAAR Study of SYD-101 in Children
Read More